Epigenetic drug boosts chemotherapy's efficacy in some lung cancers

... resistant to tyrosine kinase inhibitors," says Christine Fillmore, PhD, of Boston Children's Hospital's Stem Cell Research Program, the study's first author. EZH2 has been strongly linked with cancer progression and is part of a complex of molecules ...

http://ift.tt/1v5dugT